Patent · US Active

Recombinant RSV antigens

US8563002B2 · kind B2 · utility

36Cited by

12References

20Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Guy Jean Marie Fernand Pierre Baudoux · Rixensart, BE
Normand Blais · Laval, CA
Patrick Rheault · Oakville, CA
Jean-Louis Ruelle · Limal, BE

Key dates

Filing date	Dec 23, 2008
Grant date	Oct 22, 2013
Priority date	—
Expiry date	Oct 1, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.